BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

31 related articles for article (PubMed ID: 16919311)

  • 1. Insights into the Functional Role of ADTRP (Androgen-Dependent TFPI-Regulating Protein) in Health and Disease.
    Lupu C; Patel MM; Lupu F
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33923232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel protein ADTRP regulates TFPI expression and function in human endothelial cells in normal conditions and in response to androgen.
    Lupu C; Zhu H; Popescu NI; Wren JD; Lupu F
    Blood; 2011 Oct; 118(16):4463-71. PubMed ID: 21868574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heparin induces synthesis and secretion of tissue factor pathway inhibitor from endothelial cells in vitro.
    Hansen JB; Svensson B; Olsen R; Ezban M; Osterud B; Paulssen RH
    Thromb Haemost; 2000 Jun; 83(6):937-43. PubMed ID: 10896252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antithrombotic mechanisms of holothurian glycosaminoglycan extracted from sea cucumber].
    Shen WZ; Zhou RF; Wang XF; Ding QL; Wang HL
    Zhonghua Xue Ye Xue Za Zhi; 2006 Sep; 27(9):579-83. PubMed ID: 17278421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of native VLDL on tissue factor pathway inhibitor in endothelial cells and interactions between TFPI and lipoprotein lipase.
    Brodin E; Iversen N; Hansen JB
    J Lab Clin Med; 2006 Apr; 147(4):167-73. PubMed ID: 16581344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparanase induces tissue factor pathway inhibitor expression and extracellular accumulation in endothelial and tumor cells.
    Nadir Y; Brenner B; Gingis-Velitski S; Levy-Adam F; Ilan N; Zcharia E; Nadir E; Vlodavsky I
    Thromb Haemost; 2008 Jan; 99(1):133-41. PubMed ID: 18217145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue factor pathway inhibitor-2 is upregulated by vascular endothelial growth factor and suppresses growth factor-induced proliferation of endothelial cells.
    Xu Z; Maiti D; Kisiel W; Duh EJ
    Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2819-25. PubMed ID: 17023682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relative quantification of glycosaminoglycan-induced upregulation of TFPI-mRNA expression in vitro.
    Thyzel E; Kohli S; Siegling S; Prante C; Kleesiek K; Götting C
    Thromb Res; 2007; 119(6):785-91. PubMed ID: 16919311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heparanase, tissue factor, and cancer.
    Nadir Y; Vlodavsky I; Brenner B
    Semin Thromb Hemost; 2008 Mar; 34(2):187-94. PubMed ID: 18645924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of tissue factor pathway inhibitor in tumor growth and metastasis.
    Amirkhosravi A; Meyer T; Amaya M; Davila M; Mousa SA; Robson T; Francis JL
    Semin Thromb Hemost; 2007 Oct; 33(7):643-52. PubMed ID: 18000790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparanase coagulation and cancer progression.
    Nadir Y; Brenner B
    Best Pract Res Clin Haematol; 2009 Mar; 22(1):85-92. PubMed ID: 19285275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physiological function of tissue factor pathway inhibitor and interaction with heparins.
    Sandset PM; Bendz B; Hansen JB
    Haemostasis; 2000; 30 Suppl 2():48-56. PubMed ID: 11251341
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.